CEO Anders Hultman and CFO Ellen Dittberner present the company’s Q1’26 results – May 13, 2026
Q1 Interview: Redeye talks with CEO Anders Hultman

During a recent visit to KSB Biotech in China, IDL Diagnostics and its German partner concile explored potential additions to Concile Global’s international point-of-care testing portfolio. Discussions focused on biomarkers compatible with the reader platforms already...
IDL Diagnostics recently met with CLIA partner Zecen, and its Chinese distributors Vastec, Sysmex and Fosun, to discuss market opportunities and portfolio development. Discussions highlighted China’s national pricing-code framework, expected to be implemented by the...
CEO Gustav Sten and CFO Ellen Dittberner present the company’s Q3’26 results – November 5, 2026